News &
Notifications
Home 9 Newsroom ( Page 16 )
Newsroom
Here you will find the latest ESG and investor relations news, studies and press releases from cometis AG and our partner PRGN – Public Relations Global Network.
With the capital market panel and the investor relations panel, cometis has been conducting studies on current market events in the areas of capital markets, ESG and investor relations for several years. To this end, cometis surveys experts from the respective departments several times a year on current topics. In this context, cometis evaluates the topics and the concept and is also responsible for conducting the study.
Here, you can go directly to the respective years of Investor Relations News:
All Categories
July 14, 2020 | zooplus AG: Earnings development in the first half-year significantly above expectations – Management Board updates guidance again for the 2020 financial year
15.10.2020
Ad hoc announcement
back to the archive
zooplus AG: Management Board again updates sales and earnings guidance for the 2020 financial ...
ESG: The role of companies
09.10.2020
As unsustainable business practices become more visible, environmental, social and governance issues are becoming increasingly important for ...
ESG: What role does the legislator play?
17.09.2020
It is no secret that not only Germany, but also the EU is resolutely pushing the issue of sustainability as well as demanding and promoting ...
September 10, 2020 | Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine
10.09.2020
Corporate news
to the archive
Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 ...
10 September 2020 | Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE
10.09.2020
Ad hoc news
to the archive
Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE
Grünwald, September ...
9 September 2020 | Dermapharm publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic
09.09.2020
Corporate News
back to archive
Dermapharm publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic ...
- 4
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 5